The generic name for Anoro Ellipta is umeclidinium/vilanterol [1]. Anoro Ellipta is a combination inhaler containing two active ingredients: umeclidinium, an anticholinergic, and vilanterol, a long-acting beta2-adrenergic agonist (LABA) [1][2].
What is umeclidinium/vilanterol used for?
Umeclidinium/vilanterol is prescribed for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema [1][3]. It is not indicated for the relief of acute bronchospasm or for asthma [1].
When can generic versions of Anoro Ellipta become available?
The availability of generic versions of Anoro Ellipta depends on patent expirations and any potential legal challenges. Patent information for drugs like Anoro Ellipta can be tracked on specialized databases [4]. Without specific patent expiry dates, it's difficult to determine the exact timeline for generic availability.
How does umeclidinium/vilanterol work?
Umeclidinium works by blocking the action of acetylcholine on muscarinic receptors in the airways, leading to bronchodilation. Vilanterol stimulates beta2-adrenergic receptors in the lungs, also causing the airway muscles to relax and facilitating breathing [1][2]. This dual mechanism helps to improve airflow and reduce symptoms associated with COPD [3].
What are the potential side effects of umeclidinium/vilanterol?
Common side effects associated with umeclidinium/vilanterol include nasopharyngitis (common cold symptoms), headache, and chest pain [1]. Serious side effects can include paradoxical bronchospasm, cardiovascular effects, glaucoma, and urinary retention [1].
Are there other medications for COPD like Anoro Ellipta?
Yes, there are other long-acting bronchodilators and combination therapies available for COPD management. These include other anticholinergics, LABAs, and long-acting muscarinic antagonist/LABA combinations, as well as inhaled corticosteroids, depending on the patient's specific needs and disease severity [3].
Who manufactures Anoro Ellipta?
Anoro Ellipta is manufactured by GlaxoSmithKline (GSK) [1].
---
Sources:
[1] DrugPatentWatch.com - Anoro Ellipta - https://drugpatentwatch.com/drug/anoro-ellipta
[2] Anoro Ellipta Prescribing Information. GSK.
[3] National Institutes of Health. Chronic Obstructive Pulmonary Disease (COPD).
[4] DrugPatentWatch.com - https://drugpatentwatch.com/